About Global TravEpiNet

Global TravEpiNet is a national network of travel clinics aimed at improving the health of those who travel internationally.

About usTools for travelersFind a clinic

Global TravEpiNet Manuscripts

  1. Hyle EP, Le MH, Rao SR, Mulroy NM, Walker AT, Ryan ET, LaRocque RC. High-risk US International Travelers Seeking Pretravel Consultation During the COVID-19 Pandemic. Open Forum Infect Dis. 2022 Aug 3;9(8):ofac399. doi: 10.1093/ofid/ofac399. PMID: 36000001; PMCID: PMC9384642. Full Text.
  2. Posen HJ, Wong W, Farrar DS, Campigotto A, Chan T, Barker KR, Hagmann SHF, Ryan ET, LaRocque RC, Earl AM, Worby CJ, Castelli F, Pérez VF, Britton PN, Libman M, Hamer DH, Morris SK. Travel associated extensively drug resistant typhoid fever: a case series to inform management in non-endemic regions. J Travel Med. 2022 Jul 29:taac086. doi: 10.1093/jtm/taac086. Epub ahead of print. PMID: 35904457. Full text.
  3. Schroeder P, Brenner L, Kaur V, Cromer S, Armstrong K, LaRocque R, Ryan E, Meigs J, Florez J, Charles R, Mercader J, Leong A. Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19. Res Sq [Preprint]. 2022 Jun 1:rs.3.rs-1657002. doi: 10.21203/rs.3.rs-1657002/v1. Update in: Cardiovasc Diabetol. 2022 Jul 21;21(1):136. PMID: 35677078; PMCID: PMC9176658. Full text.
  4. Gregory DJ, Vannier A, Duey AH, Roady TJ, Dzeng RK, Pavlovic MN, Chapin MH, Mukherjee S, Wilmot H, Chronos N, Charles RC, Ryan ET, LaRocque RC, Miller TE, Garcia-Beltran WF, Thierauf JC, Iafrate AJ, Mullenbrock S, Stump MD, Wetzel RK, Polakiewicz RD, Naranbhai V, Poznansky MC. Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19. Virulence. 2022 Dec;13(1):890-902. doi: 10.1080/21505594.2022.2073025. PMID: 35587156; PMCID: PMC9122311. Full text.
  5. Tolan NV, Sherman AC, Zhou G, Nabel KG, Desjardins M, Melanson S, Kanjilal S, Moheed S, Kupelian J, Kaufman RM, Ryan ET, LaRocque RC, Branda JA, Dighe AS, Abraham J, Baden LR, Charles RC, Turbett SE. The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients. Microbiol Spectr. 2022 Mar 21:e0021122. doi: 10.1128/spectrum.00211-22. Epub ahead of print. PMID: 35311584. Full text.
  6. Turbett ISE, Becker DSM, Belford MTB, Kelly RTM, Desrosiers MTL, Oliver RNE, Branda APJA, Walters EM, Walker EAT, LaRocque APR, Ryan PET. Evaluation of Candida auris acquisition in US international travellers using a culture-based screening protocol1. J Travel Med. 2022 Jan 17;29(1):taab186. doi: 10.1093/jtm/taab186. PMID: 34875080; PMCID: PMC8763116. Full text.
  7. Bangs AC, Gastañaduy P, Neilan AM, Fiebelkorn AP, Walker AT, Rao SR, Ryan ET, LaRocque RC, Walensky RP, Hyle EP. The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad. J Pediatric Infect Dis Soc. 2022 Mar 25:piac011. doi: 10.1093/jpids/piac011. Epub ahead of print. PMID: 35333347. Full text.
  8. Nabel KG, Clark SA, Shankar S, Pan J, Clark LE, Yang P, Coscia A, McKay LGA, Varnum HH, Brusic V, Tolan NV, Zhou G, Desjardins M, Turbett SE, Kanjilal S, Sherman AC, Dighe A, LaRocque RC, Ryan ET, Tylek C, Cohen-Solal JF, Darcy AT, Tavella D, Clabbers A, Fan Y, Griffiths A, Correia IR, Seagal J, Baden LR, Charles RC, Abraham J. Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain. Science. 2021 Dec 2:eabl6251. Epub ahead of print. PMID: 34855508.
  9. Zabaleta N, Dai W, Bhatt U, Hérate C, Maisonnasse P, Chichester JA, Sanmiguel J, Estelien R, Michalson KT, Diop C, Maciorowski D, Dereuddre-Bosquet N, Cavarelli M, Gallouët AS, Naninck T, Kahlaoui N, Lemaitre J, Qi W, Hudspeth E, Cucalon A, Dyer CD, Pampena MB, Knox JJ, LaRocque RC, Charles RC, Li D, Kim M, Sheridan A, Storm N, Johnson RI, Feldman J, Hauser BM, Contreras V, Marlin R, Tsong Fang RH, Chapon C, van der Werf S, Zinn E, Ryan A, Kobayashi DT, Chauhan R, McGlynn M, Ryan ET, Schmidt AG, Price B, Honko A, Griffiths A, Yaghmour S, Hodge R, Betts MR, Freeman MW, Wilson JM, Le Grand R, Vandenberghe LH. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates. Cell Host Microbe. 2021 Sep 8;29(9):1437-1453.e8. doi: 10.1016/j.chom.2021.08.002. Epub 2021 Aug 7. PMID: 34428428; PMCID: PMC8346325. Full text.
  10. Walker AT, Gershman MD, Rao SR, LaRocque RC, Ryan ET; Global TravEpiNet Consortium. Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018. Am J Trop Med Hyg. 2021 Jan 18;104(3):1079–84. doi: 10.4269/ajtmh.19-0859. Epub ahead of print. PMID: 33534766; PMCID: PMC7941836. Full text.
  11. Sridhar S, Turbett SE, Harris JB, LaRocque RC. Antimicrobial-resistant bacteria in international travelers. Curr Opin Infect Dis. 2021 Oct 1;34(5):423-431. doi: 10.1097/QCO.0000000000000751. PMID: 34267046; PMCID: PMC8452315. Full Text
  12. Anahtar MN, Shaw BM, Slater D, Byrne EH, Botti-Lodovico Y, Adams G, Schaffner SF, Eversley J, McGrath GEG, Gogakos T, Lennerz J, Marble HD, Ritterhouse LL, Batten JM, Georgantas NZ, Pellerin R, Signorelli S, Thierauf J, Kemball M, Happi C, Grant DS, Ndiaye D, Siddle KJ, Mehta SB, Harris JB, Ryan ET, Pierce VM, LaRocque RC, Lemieux JE, Sabeti PC, Rosenberg ES, Branda JA, Turbett SE. Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay. J Clin Pathol. 2021 May 28:jclinpath-2020-207128. doi: 10.1136/jclinpath-2020-207128. Epub ahead of print. PMID: 34049977. Full Text
  13. Worby CJ, Earl AM, Turbett SE, Becker M, Rao SR, Oliver E, Taylor Walker A, Walters M, Kelly P, Leung DT, Knouse M, Hagmann SHF, Ryan ET, LaRocque RC. Acquisition and Long-term Carriage of Multidrug-Resistant Organisms in US International Travelers. Open Forum Infect Dis. 2020 Dec 21;7(12):ofaa543. doi: 10.1093/ofid/ofaa543. PMID: 33409326; PMCID: PMC7759211. Full Text
  14. Lemieux JE, Siddle KJ, Shaw BM, Loreth C, Schaffner SF, Gladden-Young A, Adams G, Fink T, Tomkins-Tinch CH, Krasilnikova LA, DeRuff KC, Rudy M, Bauer MR, Lagerborg KA, Normandin E, Chapman SB, Reilly SK, Anahtar MN, Lin AE, Carter A, Myhrvold C, Kemball ME, Chaluvadi S, Cusick C, Flowers K, Neumann A, Cerrato F, Farhat M, Slater D, Harris JB, Branda JA, Hooper D, Gaeta JM, Baggett TP, O'Connell J, Gnirke A, Lieberman TD, Philippakis A, Burns M, Brown CM, Luban J, Ryan ET, Turbett SE, LaRocque RC, Hanage WP, Gallagher GR, Madoff LC, Smole S, Pierce VM, Rosenberg E, Sabeti PC, Park DJ, MacInnis BL. Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events. Science. 2021 Feb 5;371(6529):eabe3261. doi: 10.1126/science.abe3261. Epub 2020 Dec 10. PMID: 33303686. Full text.
  15. Turbett SE, Becker M, Desrosiers L, Oliver E, Rao SR, Walker AT, Walters M, Ryan ET, LaRocque RC. ; The effect of transport temperature and time on the recovery of antimicrobial-resistant Enterobacterales in stool, Diagn Microbiol Infect Dis. 2021 Feb;99(2):115210. doi: 10.1016/j.diagmicrobio.2020.115210. Epub 2020 Sep 19. PMID: 33242837, Full Text
  16. Iyer AS, Jones FK, Nodoushani A, Kelly M, Becker M, Slater D, Mills R, Teng E, Kamruzzaman M, Garcia-Beltran WF, Astudillo M, Yang D, Miller TE, Oliver E, Fischinger S, Atyeo C, Iafrate AJ, Calderwood SB, Lauer SA, Yu J, Li Z, Feldman J, Hauser BM, Caradonna TM, Branda JA, Turbett SE, LaRocque RC, Mellon G, Barouch DH, Schmidt AG, Azman AS, Alter G, Ryan ET, Harris JB, Charles RC, Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients, Science Immunol. 2020 Oct 8;5(52):eabe0367. doi: 10.1126/sciimmunol.abe0367. PMID: 3303317, Full Text
  17. Whitman JD, Hiatt J, Mowery CT, Shy BR, Yu R, Yamamoto TN, Rathore U, Goldgof GM, Whitty C, Woo JM, Gallman AE, Miller TE, Levine AG, Nguyen DN, Bapat SP, Balcerek J, Bylsma SA, Lyons AM, Li S, Wong AW, Gillis-Buck EM, Steinhart ZB, Lee Y, Apathy R, Lipke MJ, Smith JA, Zheng T, Boothby IC, Isaza E, Chan J, Acenas DD 2nd, Lee J, Macrae TA, Kyaw TS, Wu D, Ng DL, Gu W, York VA, Eskandarian HA, Callaway PC, Warrier L, Moreno ME, Levan J, Torres L, Farrington LA, Loudermilk RP, Koshal K, Zorn KC, Garcia-Beltran WF, Yang D, Astudillo MG, Bernstein BE, Gelfand JA, Ryan ET, Charles RC, Iafrate AJ, Lennerz JK, Miller S, Chiu CY, Stramer SL, Wilson MR, Manglik A, Ye CJ, Krogan NJ, Anderson MS, Cyster JG, Ernst JD, Wu AHB, Lynch KL, Bern C, Hsu PD, Marson A, Evaluation of SARS-CoV-2 serology assays reveals a range of test performance, Nature Biotechnol 2020 Oct;38(10):1174-1183. PMID: 32855547, Full Text
  18. Miller TE, Garcia Beltran WF, Bard AZ, Gogakos T, Anahtar MN, Astudillo MG, Yang D, Thierauf J, Fisch AS, Mahowald GK, Fitzpatrick MJ, Nardi V, Feldman J, Hauser BM, Caradonna TM, Marble HD, Ritterhouse LL, Turbett SE, Batten J, Georgantas NZ, Alter G, Schmidt AG, Harris JB, Gelfand JA, Poznansky MC, Bernstein BE, Louis DN, Dighe A, Charles RC, Ryan ET, Branda JA, Pierce VM, Murali MR, Iafrate AJ, Rosenberg ES, Lennerz JK., Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital, FASEB J 2020 Aug 28;10.1096/fj.202001700RR. PMC7461169, Full Text
  19. Atyeo C, Fischinger S, Zohar T, Slein MD, Burke J, Loos C, McCulloch DJ, Newman KL, Wolf C, Yu J, Shuey K, Feldman J, Hauser BM, Caradonna T, Schmidt AG, Suscovich TJ, Linde C, Cai Y, Barouch D, Ryan ET, Charles RC, Lauffenburger D, Chu H, Alter G, Distinct Early Serological Signatures Track with SARS-CoV-2 Survival, Immunity. 2020 Sep 15;53(3):524-532.e4. PMC7392190, Full Text

  20. Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ, SARS-CoV-2 viral load is associated with increased disease severity and mortality, Massachusetts Consortium for Pathogen Readiness. Nature Commun. 2020 Oct 30;11(1):5493. PMID: 33127906, Full Text

  21. Loos C, Atyeo C, Fischinger S, Burke J, Slein MD, Streeck H, Lauffenburger D, Ryan ET, Charles RC, Alter G, Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity,  mSphere. 2020 Sep 2;5(5):e00622-20. PMC7471005, Full Text
  22. Yonker LM, Neilan AM, Bartsch Y, Patel AB, Regan J, Arya P, Gootkind E, Park G, Hardcastle M, St John A, Appleman L, Chiu ML, Fialkowski A, De la Flor D, Lima R, Bordt EA, Yockey LJ, D'Avino P, Fischinger S, Shui JE, Lerou PH, Bonventre JV, Yu XG, Ryan ET, Bassett IV, Irimia D, Edlow AG, Alter G, Li JZ, Fasano A.; Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses, J Pediatr. 2020 Aug 18:S0022-3476(20)31023-4. PMC7438214, Full Text
  23. Ogata AF, Maley AM, Wu C, Gilboa T, Norman M, Lazarovits R, Mao CP, Newton G, Chang M, Nguyen K, Kamkaew M, Zhu Q, Gibson TE, Ryan ET, Charles RC, Marasco WA, Walt DR, Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease, Clin Chem 2020 Sep 8;hvaa213. PMC7499543, Full Text

  24. Norman M, Gilboa T, Ogata AF, Maley AM, Cohen L, Busch EL, Lazarovits R, Mao CP, Cai Y, Zhang J, Feldman JE, Hauser BM, Caradonna TM, Chen B, Schmidt AG, Alter G, Charles RC, Ryan ET, Walt DR, Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19, Nature Biomed Eng 2020 Sep 18;1-8. PMC7498988, Full Text

  25. Aditya R Gandhi, BA, Sowmya R Rao, PhD, Lin H Chen, MD, Michael D Nelson, MD, MPH&TM, Edward T Ryan, MD, Regina C LaRocque, MD, MPH, Emily P Hyle, MD, MSc; Prescribing patterns of antibiotics for the self-treatment of travelers’ diarrhea in Global TravEpiNet, 2009-2018, Open Forum Infectious Diseases, 26 August 2020, ofaa376, Full Text
  26. Turbett SE, Desrosiers L, Andrews-Dunleavey C, Becker M, Walker AT, Esposito D, Woodworth KR, Branda JA, Rosenberg E, Ryan ET, LaRocque R.; Evaluation of a Screening Method for the Detection of Colistin-Resistant Enterobacteriaceae in Stool, Open Forum Infect Dis. 2019 May 6;6(6):ofz211. doi: 10.1093/ofid/ofz211. eCollection 2019 Jun. PMID: 31211157, Full Text
  27. Mellon G, Turbett SE, Worby C, Oliver E, Walker AT, Walters M, Kelly P, Leung DT, Knouse M, Hagmann S, Earl A, Ryan ET, LaRocque RC; Acquisition of Antibiotic-Resistant Bacteria by U.S. International Travelers, N Engl J Med. 2020 Apr 2;382(14):1372-1374. doi: 10.1056/NEJMc1912464. Full Text.

  28. Hyle EP, Rao SR, Bangs AC, Gastañaduy P, Fiebelkorn AP, Hagmann SHF, Walker AT, Walensky RP, Ryan ET, LaRocque RC; Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers. JAMA Pediatr. 2019 Dec 9:e194515. doi: 10.1001/jamapediatrics.2019.4515. Full Text.

  29. Yates JA, Rao SR, Walker AT, Esposito DH, Sotir M, LaRocque RC, Ryan ET; Global TravEpiNet Consortium; Characteristics and preparation of the last-minute traveler: analysis of vaccine usage in the Global TravEpiNet Consortium. J Travel Med. 2019 Sep 2;26(6). pii: taz031. doi: 10.1093/jtm/taz031.  Full Text.

  30. Sbaih N, Buss B, Goyal D, Rao SR, Benefield R, Walker AT, Esposito DH, Ryan ET, LaRocque RC, Leung DT; Global TravEpiNet Consortium; Potentially Serious Drug Interactions Resulting From the Pretravel Health Encounter. J Travel Med. 2019 Sep 2;26(6). pii: taz031. doi: 10.1093/jtm/taz031. Full Text.
  31. Hyle EP, Fields NF, Fiebelkorn AP, Walker AT, Gastañaduy P, Rao SR, Ryan ET, LaRocque RC, Walensky RP; The Clinical Impact and Cost-effectiveness of MMR Vaccination to Prevent Measles Importations among US International Travelers, Clin Infect Dis. 2018 Oct 11. doi: 10.1093/cid/ciy861. Full Text
  32. Nadine Sbaih, Brian Buss, Dheeraj Goyal, Sowmya R Rao, Russell Benefield, Allison Taylor Walker, Douglas H Esposito, Edward T Ryan, Regina C LaRocque, Daniel T Leung, Global TravEpiNet Consortium; Potentially Serious Drug Interactions Resulting From the Pretravel Health Encounter, Open Forum Infectious Diseases, Volume 5, Issue 11, 1 November 2018, ofy266, Full Text
  33. R Ryan Lash, PhD, MA Allison Taylor Walker, PhD, MPH C Virginia Lee, MD, MPH, MA Regina LaRocque, MD, MPH Sowmya R Rao, PhD Edward T Ryan, MD Gary Brunette, MD, MS Kelly Holton, BA Mark J Sotir, PhD, MPH; Enabling clinicians to easily find location-based travel health recommendations—is innovation needed? J Travel Med. 2018 Jan 1;25(1). Full Text.
  34. Hagmann SHF, Rao SR, LaRocque RC, Erskine S, Jentes ES, Walker AT, Barnett ED, Chen LH, Hamer DH, Ryan ET; Global TravEpiNet Consortium and the Boston Area Travel Medicine Network. Travel Characteristics and Pretravel Health Care Among Pregnant or Breastfeeding U.S. Women Preparing for International Travel. Obstet Gynecol. 2017 Dec;130(6):1357-1365. Full Text.
  35. Leung DT, LaRocque RC, Ryan ET. Travel Medicine. Ann Intern Med. 2018 Jan 2;168(1):ITC1-ITC16. Full Text.
  36. Hyle EP, Rao SR, Jentes ES, Fiebelkorn AP, Hagmann SHF, Walker AT, Walensky RP, Ryan ET, LaRocque RC. Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations. Ann Intern Med. 2017; 10.7326/M16-2249. PMID: 28505632. Full Text.
  37. Lammert S, Walker AT, Erskine S, Rao SR, Esposito DH, Ryan ET, Robbins GK, LaRocque RC. Characteristics of US Travelers to Zika Virus-Affected Countries in the Americas, March 2015-October 2016. Emerg Infect Dis. 2017 Feb; 23(2):324-327. PMID: 27926355. Full Text.
  38. Lammert SM, Rao SR, Jentes ES, Fairley JK, Erskine S, Walker AT, Hagmann SH, Sotir MJ, Ryan ET, LaRocque RC. Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet. J Travel Med. 2016 Oct 30. Full Text.
  39. LaRocque RC, Ryan ET. Personal Actions to Minimize Mosquito-Borne Illnesses, Including Zika Virus.Ann Intern Med. 2016;10.7326/M16-1397. Full Text.
  40. Khan NM, Jentes ES, Brown C, Han P, Rao SR, Kozarsky P, Hagmann SH, LaRocque RC, Ryan ET, and the Global TravEpiNet Consortium (GTEN). Pre-Travel Medical Preparation of Business and Occupational Travelers: An Analysis of the Global TravEpiNet Consortium, 2009 to 2012. Occup Environ Med. 2015 Oct 15. [Epub ahead of print]
  41. Schwartz BS, Rosen J, Han PV, Hynes NA, Hagmann SH, Rao SR, Jentes ES, Ryan ET, LaRocque RC, and the Global TravEpiNet Consortium. Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg. 2015 Aug 24. [Epub ahead of print]
  42. Adachi K, Coleman MS, Khan N, Jentes ES, Arguin P, Rao SR, LaRocque RC, Sotir MJ, Brunette G, Ryan ET, Meltzer MI, and the Global TravEpiNet Consortium. Economics of Malaria Prevention in US Travelers to West Africa. Clin Infect Dis. 2014;58(1):11-21.
  43. Rao SR, LaRocque RC, Jentes ES, Hagmann SH, Ryan ET, Han PV, Kleinbaum DG, and Global TravEpiNet Consortium. Comparison of Methods for Clustered Data Analysis in a Non-Ideal Situation: Results from an Evaluation of Predictors of Yellow Fever Vaccine Refusal in the Global TravEpiNet (GTEN) Consortium. Int J Stat Med Res. 2014;3:215-223. Full Text.
  44. Deshpande BR, Rao SR, Jentes ES, Hills SL, Fischer M, Gershman MD, Brunette GW, Ryan ET, LaRocque RC, and the Global TravEpiNet Consortium. Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet. Am J Trop Med Hyg. 2014;91(4):694-698. Full Text.
  45. Dolan SB, Jentes ES, Sotir MJ, Han P, Blanton JD, Rao SR, LaRocque RC, Ryan ET, and the Global TravEpiNet Consortium. Pre-Exposure Rabies Vaccination among US International Travelers: Findings from the Global TravEpiNet Consortium. Vector Borne Zoonotic Dis. 2014;14(2):160-167. Full Text
  46. Stoney RJ, Jentes ES, Sotir MJ, Kozarsky P, Rao SR, Larocque RC, Ryan ET, and the Global TravEpiNet Consortium. Pre-travel Preparation of US Travelers Going Abroad to Provide Humanitarian Service, Global TravEpiNet 2009-2011. Am J Trop Med Hyg. 2014;90(3):553-9. 
  47. Hagmann S, LaRocque RC, Rao SR, Jentes ES, Sotir MJ, Brunette G, Ryan ET, and the Global TravEpiNet Consortium. Editor's Choice: Pre-Travel Health Preparation of Pediatric International Travelers: Analysis From the Global TravEpiNet Consortium. J Ped Infect Dis. 2013;2(4):327-334. Full Text.
  48. Jentes ES, Han P, Gershman MD, Rao SR, LaRocque RC, Staples JE, Ryan ET, and the Global TravEpiNet Consortium. Travel Characteristics and Yellow Fever Vaccine Usage Among US Global TravEpiNet Travelers Visiting Countries with Risk of Yellow Fever Virus Transmission, 2009-2011. Am J Trop Med Hyg.2013;88(5):954-961. Full Text
  49. LaRocque RC, Deshpande B, Rao SR, Brunette G, Sotir M, Jentes ES, Ryan ET, and the Global TravEpiNet Consortium. Pre-Travel Health Care of Immigrants Returning Home to Visit Friends and Relatives. Am J Trop Med Hyg. 2013;88(2):376-380. Full Text
  50. LaRocque RC, Rao SR, Lee J, Ansdell V, Yates, JA, Schwartz BS, Knouse M, Cahill J, Hagmann S, Vinetz J, Connor B, Goad J, Oladele A, Alvarez S, Stauffer W, Walker P, Kozarsky P, Franco-Paredes C, Dismukes R, Rosen J, Hynes N, Jacquerioz F, McLellan S, Hale D, Sofarelli T, Schoenfeld D, Marano N, Brunette G, Yanni E, Jentes ES, Sotir M, Ryan ET, and the Global TravEpiNet Consortium. Global TravEpiNet: A National Consortium of Clinics Providing Care to International Travelers—Analysis of Demographic Characteristics, Travel Destinations, and Pretravel Healthcare of High-Risk US International Travelers, 2009–2011. Clin Infect Dis. 2011;54(4):455-462.
  51. LaRocque RC, Jentes ES. Health Recommendations for International Travel: A Review of the Evidence Base of Travel Medicine. Curr Opin Infect Dis. 2011;24(5):403-409. Full Text
  52. LaRocque RC, Rao SR, Tsibris A, Lawton T, Barry MA, Marano N, Brunette G, Yanni E, Ryan, ET. Pre-Travel Advice-Seeking Behavior among US International Travelers Departing from Boston Logan International Airport. J Travel Med. 2010;17(6):387-391. 

Peer-Reviewed Abstracts and Posters

  1. Hyle, E., Rao, S., Jentes, E., Fiebelkorn, A.P., Hagmann, S., Walensky, R., Ryan, E.T., and Larocque, R. Pre-Travel Assessment of Measles Immunity Status and Administration of MMR for Adult International Travelers seen in Global TravEpiNet Sites. IDSA, San Diego, CA, 2015.
  2. Lammert, S., Erskine, S., Jentes, E., Rao, S.R., Hagmann, S., MacAulay, B., Morse, R., Ryan, E.T., LaRocque, R. Development and Usage of Internet Tools to Improve Travelers’ Health: Pre-Travel PREP and TRhIP. 14th Conference of the International Society of Travel Medicine, Quebec City, QC, 2015.
  3. Lammert, S., Jentes, E.S., Erskine, S., Hagmann, S., Rao, S.R., Ryan, E.T., LaRocque, R. Refusal of Recommended Vaccines Among U.S. International Travelers in Global TravEpiNet. 14th Conference of the International Society of Travel Medicine, Quebec City, QC, 2015.
  4. Hagmann, S., Rao, S.R., LaRocque, R.C., Erskine, S., Jentes, E.S., Ryan, E.T. Travel Characteristics and Pre-Travel Health Care among Pregnant or Breastfeeding Women Preparing for International Travel: Analysis for the U.S. Global TravEpiNet Consortium. 14th Conference of the International Society of Travel Medicine, Quebec City, QC, 2015.
  5. Deshpande B, Rao S, Brunette G, Sotir M, Gershman M, Jentes E, Hills S, Fischer M, Ryan ET, LaRocque R. Use of Japanese Encephalitis Vaccine in U.S. Travel Medicine Practices in Global TravEpiNet. 62nd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington, D.C., 2013.
  6. Coleman, M.S., Adachi, K., Khan, N., Jentes, E.J., Arguin, P., Rao, S.R., LaRocque, R.C., Sotir, M.J., Brunette, G., Ryan, E.T., Meltzer, M.I. Economics of Malaria Prevention in United States Travelers to West Africa. 13th Conference of the International Society of Travel Medicine, Maastricht, Netherlands, 2013.
  7. Schwartz, B., Rosen, J., Han, P., Hynes, N.A., Rao, S.R., Jentes, E.S., LaRocque, R.C., Ryan, E.T. Immunocompromised Travelers from the U.S.: Demographic Characteristics, Travel Destinations, and Pre-Travel Health Care from the U.S. Global TravEpiNet Consortium. 13th Conference of the International Society of Travel Medicine, Maastricht, Netherlands, 2013.
  8. LaRocque, R.C., Deshpande, B., Rao, S.R., Brunette, G.W., Sotir, M.J., Jentes, E.S., Ryan, E.T. Pre-Travel Health Care of Immigrants Returning Home to Visit Friends and Relatives. 13th Conference of the International Society of Travel Medicine, Maastricht, Netherlands, 2013.
  9. LaRocque, R.C., Deshpande, B., Rao, S.R., Brunette, G.W., Gershman, M.D., Jentes, E.S., Hills, S.L., Fischer, M., Ryan, E.T. Japanese Encephalitis Vaccine Administration Practices Among U.S. Travel Medicine Practices in Global TravEpiNet. 13th Conference of the International Society of Travel Medicine, Maastricht, Netherlands, 2013.
  10. Rao, S.R., LaRocque, R.C., Han, P., Jentes, E.S., Kleinbaum, D., Ryan, E.T. Comparison of Methods for Clustered Data Analysis in a Non-Ideal Situation: Results from the Global TravEpi Network (GTEN). International Indian Statistical Association Conference: Chennai, India, 2013. 
  11. Schwartz B, Rosen J, Han P, Hynes N, Rao S, Jentes E, LaRocque R, Ryan E. Immunocompromised International Travelers from the United States, 2009-2011: Preliminary Analysis of Demographic Characteristics, Travel Destinations, and Pre-travel Health Care from the Global TravEpiNet Consortium, IDSA, 2012.
  12. Dolan, S., Jentes, E.S., Sotir, M.J., Han, P., Blanton, J., Rao, S.R., LaRocque, R.C., Ryan, E.T., and the Global TravEpiNet Consortium. Pre-Travel Rabies Vaccine Use among U.S. travelers seen at Global TravEpiNet Clinics. International Conference on Emerging Infectious Diseases, Atlanta, GA, 2012.
  13. Stoney R., Jentes E.S., Sotir M.J., Kozarsky P., Rao S.R., LaRocque R., Ryan E.T., and the Global TravEpiNet Consortium. Pre-Travel Preparation of US Travelers Going Abroad to Provide Humanitarian Service, Global TravEpiNet 2009-2010. Sixtieth Annual Meeting of the American Society of Tropical Medicine and Hygiene: Philadelphia, PA, 2011.
  14. Jentes, E.S., Han, P., Rao, S.R., LaRocque, R., Kozarsky, P., Ryan, E.T., and the Global TravEpiNet Consortium. Demographics, Destinations, and Yellow Fever Vaccine Usage Among US Travelers Visiting Countries with Risk of Yellow Fever Virus Transmission. 12th Conference of the International Society of Travel Medicine: Boston, MA. 2011.
  15. LaRocque, R.C., Rao, S.R., Lee, J., Ansdell, V., Schwartz, B.S., Knouse, M., Cahill, J., Hagmann, S., Vinetz, J., Connor, B., Goad, J., Oladele, A., Alvarez, S., Stauffer, W., Walker, P., Kozarsky, P., Franco-Paredes, C., Dismukes, R., Rosen, J., Schoenfeld, D., Marano, N., Brunette, G., Yanni, E., Jentes, E., Sotir, M., Ryan, E.T., and the Global TravEpiNet Consortium. Demographics, Travel Destinations and Pre-Travel Health Care Among U.S. International Travelers: Analysis of the Global TravEpiNet Surveillance Network. 12th Conference of the International Society of Travel Medicine: Boston, MA, 2011.
  16. LaRocque, R.C. Global TravEpiNet: A Web-Based Data Collection Tool for Travel Medicine. 12th Conference of the International Society of Travel Medicine, Boston, MA, 2011.
  17. Hagmann, S., LaRocque, R.C., Rao, S.R., Jentes, E.S., Ryan, E.T. Pediatric International Travelers and Travel Health Preparations: Analysis from the U.S. Global TravEpiNet Consortium. 12th Conference of the International Society of Travel Medicine: Boston, MA, 2011